
Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
Supplements and Featured Publications
In this AJMC® Profiles in Care, key stakeholders affiliated with Keck Medicine of the University of Southern California and the Rancho Los Amigos National Rehabilitation Center in southern California share best practices for development of a limb salvage program for people with peripheral artery disease and others at high risk of limb amputation.
almost 3 years ago
Inova Health System Center of Excellence





